Jamie Wine is an accomplished trial lawyer and a Fellow in the American College of Trial Lawyers. Her recent wins include a trial victory in Delaware Chancery Court for Scilex Pharmaceuticals in a breach of fiduciary duty and misappropriation of trades secret case against its former President and CEO, the dismissal of a highly-publicized defamation suit against Chess.com relating to a chess grandmaster cheating scandal, the dismissal of a high-profile equal pay lawsuit brought by the US Women’s National Soccer team against the US Soccer Federation, and the dismissal of a US$2 billion securities class action and the winning of a US$666 million award in a post M&A dispute for DXC Technology Corporation.

In addition to her trial practice, Jamie regularly advises a number of issuers, each of the Big Four accounting firms, and various financial institutions on a variety of complex commercial and securities litigation matters, as well as SEC and other regulatory investigations.

Jamie is widely recognized for her excellence. She has been praised by leading publications and was a finalist for The American Lawyer’s Litigator of the Year (2020). She is consistently featured as a leading litigator and trial lawyer by Chambers USA, Benchmark Litigation, and Lawdragon.

Jamie formerly served as Global Chair of Latham’s Litigation & Trial Department, and prior to that, as a member of the firm’s Executive Committee. She is a longstanding member of the Board of the Legal Aid Society.

Jamie's experience includes:

  • Won plaintiffs-side trial victory in the Delaware Court of Chancery for Sorrento Therapeutics and Scilex Pharmaceuticals in breach of fiduciary duty, breach of contract, and misappropriation of trade secrets case
  • Won dismissal of defamation and antitrust claims against Chess.com in highly-publicized chess grandmaster cheating scandal
  • Won US$125 million as lead trial counsel for Sorrento Therapeutics in a breach of contract case over the failed development efforts of a Phase III cancer drug
  • Successfully resolved securities class action claims against Covetrus and its senior officers, and obtained voluntary dismissal of stockholder derivative claims against board of directors
  • Won complete victory as lead trial counsel in a post M&A dispute for a Fortune 500 company defeating US$1 billion claim and winning US$70 million counterclaim
  • Won US$666 million as lead trial counsel for DXC Technology Company against Hewlett Packard Enterprise Company in a post-M&A dispute
  • Won dismissal of stockholder derivative claims and related federal securities class action lawsuits against DXC Technology Company and its directors and officers
  • Won a high-profile summary judgment victory for the US Soccer Federation as lead trial counsel in its litigation with the US Senior Women’s National Team regarding equal pay
  • Won complete dismissal, on a motion to dismiss, for Booz Allen in a securities class action in the SDNY related to the sale of its government business to The Carlyle Group; also acted as lead trial counsel in a related individual securities fraud suit, which reached favorable settlement during trial
  • Won complete defense victory as lead trial counsel in an arbitration for a Big Four accounting firm brought by the Trustee of its former audit client
  • Won complete dismissal, on a motion to dismiss and affirmed on appeal, for Ferrellgas, Inc. in a securities class action in the SDNY relating to statements about a corporate acquisition and the effect of declining crude oil prices on the business
  • Won complete dismissal, on a motion to dismiss, for Aratana Therapeutics, Inc. in a securities class action in the SDNY relating to the timing and release of a new FDA-approved drug
  • Won complete dismissal, on a motion to dismiss, for Pacira Pharmaceuticals, Inc. in a securities class action in the District of New Jersey relating to statements about product safety and efficacy
  • Reached favorable settlement for HCA, Inc. in a securities class action in the District of Tennessee alleging omission of purported revenue trends in IPO offering materials
  • Won complete defense victory for Ernst & Young as lead trial counsel in an arbitration brought by the Lehman Creditors Committee, and won dismissal of all Section 11 and most Section 10b claims in the Lehman multi-district shareholder litigation in the SDNY
  • Represented Deutsche Bank in numerous federal and state actions across the US related to RMBS
  • Lead trial counsel in successful arbitration of a multi-million dollar confidential tax shelter matter for a Big Four accounting firm
  • Won complete trial victory, confirmed on appeal, for a KPMG audit partner in an SEC proceeding alleging improper professional conduct related to Royal Ahold
  • Won complete dismissal, on summary judgment and affirmed on appeal, for Caesars Bahamas Investment Corp. (Harrah’s) in a dispute regarding the multi-billion dollar Baha Mar casino resort project
  • Won complete dismissal, on summary judgment, in one class action and reached favorable settlement in the other for Ernst & Young relating to its audits of The Williams Companies
  • Won complete dismissal for PricewaterhouseCoopers on summary judgment, affirmed on appeal, in a securities class action relating to its audits of Chantal Pharmaceuticals

Bar Qualification

  • California
  • District of Columbia
  • New York
  • Vermont

Education

  • JD, Harvard Law School, 1995
  • BA, Lehigh University, 1992